Advances in Translational Research and Clinical Care in Pancreatic Cancer: Where Are We Headed?

While significant advances have been made in the treatment of many different solid tumors, pancreatic cancer remains a glaring exception. Overall 5-year survival rates for pancreatic cancer remain in the single digits. While newer chemotherapy regimens such as FOLFIRINOX and nab-paclitaxel/gemcitabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Satyananda, Vikas, Gupta, Rohan, Hari, Danielle M., Yeh, James, Chen, Kathryn T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378762/
https://www.ncbi.nlm.nih.gov/pubmed/30863442
http://dx.doi.org/10.1155/2019/7690528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378762/
https://www.ncbi.nlm.nih.gov/pubmed/30863442
http://dx.doi.org/10.1155/2019/7690528

Ejemplares similares